Georgia hospitals launch trials of a promising pancreatic cancer drug
Researchers at Emory University’s Winship Cancer Institute and Piedmont Atlanta Hospital are testing daraxonrasib, an experimental pancreatic cancer drug, after FDA early-access approval; early results show tumor shrinkage with fewer side effects than standard chemotherapy, offering hope for patients facing one of the deadliest cancers.